Hideto Kameda - 1Division of Rheumatology-Department of Internal Medicine, Toho University

基本信息

浏览量：15

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 248 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Recommendations for the Treatment of Juvenile Idiopathic Arthritis with Oligoarthritis or Polyarthritis from the 2024 Update of the Japan College of Rheumatology Clinical Practice Guidelines for the Management of Rheumatoid Arthritis Including Juvenile Idiopathic Arthritis with Oligoarthritis or Polyarthritis- Secondary Publicat..

Takako Miyamae,Nami Okamoto,Yuzaburo Inoue,Tomohiro Kubota, Takasuke Ebato,Hitoshi Irabu,Hideto Kameda,Yuko Kaneko,Hiroshi Kubo, Kanako Mitsunaga,Masaaki Mori,Ayako Nakajima,Kenichi Nishimura, Naoaki Ohkubo,Tomomi Sato, Yuko Sugita,Satoshi Takanashi, Takayuki Tanaka,Hiroaki Umebayashi,Masato Yashiro,Shingo Yamanishi, Mie Fusama,Shintaro Hirata,Mitsumasa Kishimoto,Masataka Kohno,Masayo Kojima,Toshihisa Kojima,Akio Morinobu,Takahiko Sugihara,Eiichi Tanaka,Nobuyuki Yajima,Ryo Yanai,Yutaka Kawahito,Masayoshi Harigai

Modern rheumatology (2025)

引用0浏览0WOS引用

Secukinumab Persistence in Patients with Psoriatic Arthritis: an Adalimumab-Matched Retrospective Cohort Database Study (FLYWAY)

Hideto Kameda, Kentaro Ishii, Junna Kiriyama, Toshiaki Mikami, Hideya Uratsuji,Akimichi Morita

Rheumatology and Therapyno. 3 (2025): 493-511

引用0浏览0WOS引用

Synergistic Improvements in Synovitis, Enthesitis, and Patient-Reported Outcomes for Patients with Psoriatic Arthritis Treated with Ixekizumab in SPIRIT Trials

Lars-Erik Kristensen,Dennis McGonagle,Martin Rudwaleit,Hideto Kameda, Peter Adler Würtzen,Marcus Ngantcha,Thorsten Holzkämper,Josef Smolen

Rheumatology and Therapyno. 2 (2025): 381-395

引用0浏览0WOS引用

Anticytokine (ligand) Antibody Versus Antireceptor Antibody in Treating Rheumatoid Arthritis and Other Immune-Mediated Inflammatory Diseases

Hideto Kameda, Reina Maezawa, Yasuto Minegishi,Chihiro Imaizumi,Takehisa Ogura

International journal of rheumatic diseasesno. 4 (2025): e70202-e70202

引用0浏览0WOS引用

Sarilumab in the Treatment of Rheumatoid Arthritis: Future Perspectives

Hideto Kameda, Reina Maezawa, Yasuto Minegishi,Chihiro Imaizumi, Takaharu Katagiri,Takehisa Ogura

Expert opinion on biological therapypp.1-3, (2025)

引用0浏览0WOS引用

Serum Cytokine Levels Towards Precision Medicine in Still's Disease: a Subanalysis of a Randomized Controlled Trial of Tocilizumab

Koji Suzuki,Hideto Kameda,Kei Ikeda,Tomonori Ishii,Kosaku Murakami,Hyota Takamatsu,Yoshiya Tanaka,Takayuki Abe,Tsutomu Takeuchi,Yuko Kaneko

Rheumatology (Oxford, England) (2025)

引用0浏览0WOS引用

Safety of Sarilumab in a Japanese Population with Rheumatoid Arthritis by Age Group: Data from an Interim Analysis of a Post-Marketing Surveillance Study

Hideto Kameda,Sadatomo Tasaka,Toshiya Takahashi, Katsuhisa Suzuki, Naoki Soeda,Hubert van Hoogstraten, Remco Diab,Yoshiya Tanaka

Modern Rheumatology (2024)

引用0浏览0WOS引用

Safety and Effectiveness of Certolizumab Pegol in Japanese Patients with Rheumatoid Arthritis: Up to 3-Year Results from a Postmarketing Surveillance Study

Hideto Kameda,Keiichiro Nishida,Toshihiro Nanki, Akira Watanabe,Yukiya Oshima,Shigeki Momohara

Modern Rheumatology（2024）

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn